JACC-HEART FAILURE Journal
Overview
publication venue for
- Obesity, Challenges, and Weight-Loss Strategies for Patients With Ventricular Assist Devices 2024
- Obesity and Weight Loss Strategies for Patients With Heart Failure 2024
- Considerations in the Diagnosis and Management of Pulmonary Hypertension Associated With Left Heart Disease 2024
- Increasing Utilization of Extended Criteria Donor Hearts for Transplantation The OCS Heart EXPAND Trial. 12:438-447. 2024
- Increasing Utilization of Extended Criteria Donor Hearts for Transplantation. 12:438-447. 2024
- Hospitalization Patterns and Impact of a Magnetically-Levitated Left Ventricular Assist Device in the MOMENTUM 3 Trial. 10:470-481. 2022
- Rinse, Wash, Repeat The Evolution of the UNOS Heart Transplant Allocation System COMMENT 2022
- Splanchnic Nerve Block Mediated Changes in Stressed Blood Volume in Heart Failure. 9:293-300. 2021
- Splanchnic Nerve Block for Chronic Heart Failure. 8:742-752. 2020
- Reassessing Recipient Mortality Under the New Heart Allocation System An Updated UNOS Registry Analysis. 8:548-556. 2020
- Durability and Efficacy of Tricuspid Valve Repair in Patients Undergoing Left Ventricular Assist Device Implantation. 8:141-150. 2020
- Caregivers of Patients Considering a Destination Therapy Left Ventricular Assist Device and a Shared Decision-Making Intervention The DECIDE-LVAD Trial. 6:904-913. 2018
- Long-Chain Omega-3 Fatty Acid Supplements in Depressed Heart Failure Patients Results of the OCEAN Trial. 6:833-843. 2018
- Weighty Matters in HFpEF and Aging 2018
- Cardiac Rehabilitation After Ventricular Assist Device Implantation A Worthwhile Exercise? 2018
- Demanding Truth in a Complex Heart Allocation System 2017
- Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients. 5:823-832. 2017
- The HVAD Left Ventricular Assist Device Risk Factors for Neurological Events and Risk Mitigation Strategies. 3:818-828. 2015
- Gastrointestinal Bleeding in Recipients of the HeartWare Ventricular Assist System. 3:303-313. 2015
- The Heartmate Risk Score Predicts Morbidity and Mortality in Unselected Left Ventricular Assist Device Recipients and Risk Stratifies INTERMACS Class 1 Patients. 3:283-290. 2015
- Clinical Outcomes With Use of Erythropoiesis Stimulating Agents in Patients With the HeartMate II Left Ventricular Assist Device. 3:146-153. 2015
- Effects of Left Ventricular Assist Device Support on Biomarkers of Cardiovascular Stress, Fibrosis, Fluid Homeostasis, Inflammation, and Renal Injury. 3:30-39. 2015
Research
category
- CARDIAC & CARDIOVASCULAR SYSTEMS Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 2213-1779
Electronic International Standard Serial Number (EISSN)
- 2213-1787
Other
journal abbreviation
- JACC-HEART FAIL